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Mutations of the TIGR/MYOC Gene in Primary
Open-Angle Glaucoma in Korea
To the Editor:
Glaucoma affects 13.5 million people in North America.
Although treatable in the early stages, often it is not
diagnosed and treated in time, which results in irre-
versible blindness. Primary open-angle glaucoma
(POAG), the most common form of glaucoma, repre-
sents 150% of glaucoma cases in Western countries
(Raymond 1997). POAG is an eye disorder characterized
by the progressive excavation of optic disks, typical vi-
sual-field defects, and optic-nerve damage. Many fam-
ilies with autosomal dominant POAG have been re-
ported (Brezin et al. 1997). The initial finding of a
linkage between the juvenile-onset form of POAG
(JOAG) and markers at the GLC1A locus on 1q21–31
(Sheffield et al. 1993) was subsequently confirmed
in other families (MIM 137750). Recently, Stone et
al. (1997) showed that mutations of the TIGR/MYOC
(trabecular meshwork–induced glucocorticoid-response
protein/myocilin) gene (MIM 601652), which maps at
the GLC1A locus, were responsible for JOAG, as well
as for middle-age–onset POAG. After publication of that
report, other investigators have described various mu-
tations in TIGR/MYOC in patients with JOAG/POAG
(Adam et al. 1997; Suzuki et al. 1997; Mansergh et al.
1998; Michels-Rautenstrauss et al. 1998). Although a
few mutations were found in different exons (Alward et
al. 1998), most mutations reported to date are clustered
in the third exon. This exon is evolutionarily conserved
and bears sequence homology with the olfactomedin
gene (Yokoe and Anolt 1993). We investigated whether
Korean patients with JOAG/POAG have the mutations
of the TIGR/MYOC gene. In our report we present two
patients whose genomes harbor different TIGR/MYOC
gene mutations.
After obtaining informed consent, we collected pe-
ripheral-blood samples from 45 unrelated patients with
POAG who visited the Department of Ophthalmology
at the Catholic University Medical Center, Korea. The
patients were given diagnoses of POAG on the basis of
findings from ocular examinations. Patients with POAG
were determined to be affected if intraocular pressure
(IOP) was 122 mmHg in both eyes and if the cup/disk
ratio was 10.3, with characteristic visual-field loss and
gonioscopic grade III or IV. Blood samples were also
obtained from 106 patients who had visited the Catholic
University Medical Center because of diseases other than
POAG and who served as controls. Genomic DNA was
extracted from each blood sample by means of DNA-
isolation kits for mammalian blood (Boehringer Mann-
heim). The DNA fragments encoding portions of TIGR/
MYOC protein were amplified by means of PCR and
were analyzed by cold SSCP. The primers used for PCR
are shown in table 1. The nucleotide numbers corre-
spond to those in the work of Nguyen et al. (1998). A
PCR reaction was performed in a 30-ml volume con-
taining 50 ng of genomic DNA, 0.2 mM each of forward
and reverse primers, 0.19 mM of each deoxyribonucle-
otide triphosphate (dATP, dCTP, dGTP, and dTTP), 50
mM KCl, 1.5 mM MgCl2, and 10 mM Tris-HCl, pH
8.3. The PCR product was denatured and separated on
a 20% polyacrylamid Tris-borate EDTA gel (Novex).
The DNA fragments were visualized by staining the gel
with ethidium bromide solution. The PCR products ex-
hibiting aberrant SSCP patterns were subcloned and se-
quenced by means of an ALF express DNA sequencer
(Pharmacia) with fluorescent dye–primer chemistry.
Multiple clones were sequenced to confirm the presence
of both normal and mutant clones.
Of the 45 patients who were screened for mutations,
2 were found to carry variants in theTIGR/MYOC gene.
We were able to recruit one patient for a family study.
This family consists of five members (fig. 1A). The pro-
band (individual 3; fig. 1A) was given a diagnosis of
JOAG at age 15 years. At the time of diagnosis, her IOPs
were 29 mmHg (right eye [OD]) and 30 mmHg (left eye
[OS]), and she exhibited severe visual-field loss and op-
tic-nerve damage. Because the disease progressed ag-
gressively and medical treatment was not effective, sur-
gery was required to control the progress of glaucoma
in both eyes. None of the other family members was
given a diagnosis of POAG, although individuals 1, 2,
and 4 had slightly elevated IOPs compared with indi-
vidual 5 (table 2), as well as with those in the control
group.
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Figure 1 Pedigree of a family, analysis of SSCP, and sequences
of regions with mutations in the TIGR/MYOC gene. A, Pedigree of
a family with the C201T mutation. The unblackened symbol denotes
a genotypically and phenotypically unaffected individual. The black-
ened symbol indicates an individual with documented evidence of
POAG. A symbol with a dot indicates an obligatory carrier. The arrow
indicates the proband. B, SSCP analysis of C201T (lanes 1–5) and
C1123T (lanes 6 and 7) mutations, described in the text. Lane M,
HaeIII fragments of f# 174RF. Lanes 1, 2, 4, and 6, Heterozygotes.
Lane 3, Homozygote. Lanes 5 and 7, Normal.C, Sequence comparison
between the TIGR/MYOC gene harboring mutations and the wild
type. The altered nucleotides are shown in boldface and are denoted
by an asterisk (*). Rows TIGR, wild-type sequence. Rows mTIGR,
sequence from patients with POAG.
Table 1
Primer Sequences for PCR and Conditions for PCR and SSCP
REGION
(nta)
SEQUENCE
TEMPERATURE
(C)
PRODUCT
SIZE
(bp)Forward Reverse
Annealing,
for PCR
Running,
for SSCPb
88 to 281 5′-TGTGCACGTTGCTGCAGC-3′ 5′-ATGGATGACTGACATGGCC-3′ 56 10 204
1014 to 1202 5′-ATACTGCCTAGGCCACTGG-3′ 5′-CAATGTCCGTGTAGCCACC-3′ 62 14 189
1296 to 1493 5′CTGGAACTCGAACAAACCTGG-3′ 5′-CATGCTGCTGTACTTATAGCG-3′ 60 8 198
83 to 281 5′-TGGCCACCTCTGTCTTCC -3′ 5′-ATGGATGACTGACATGGCC-3′ 60 384
177 to int1A 5′- AGGAAGGCCAATGACCAG -3′ 5′-TAGGAGAAAGGGCAGGGGAGGC -3′ 62 593
int1B to 795 5′-AACATAGTCAATCCTTGGGCC -3′ 5′- CGGTGTCTCCCTCTCCACT -3′ 56 170
796 to 1316 5′-GATGTGGAGGACTAGTTTGG -3′ 5′- CCAGGTTTGTTCGAGTTCCAG -3′ 56 521
1296 to 3′UTR 5′-CTGGAACTCGAACAAACCTGG-3′ 5′-GCTTGGAGGCTTTTCACATC-3′ 60 283
a Numbers correspond to those in the work of Nguyen et al. (1998).
b Three parts of the MYOC coding region were analyzed by SSCP, and the rest were used for sequencing the MYOC gene of the proband,
individual 3.
Another patient whom we were unable to recruit for
a family study received a diagnosis of POAG at age 59
years and displayed a moderate phenotype. Her IOPs
before medication treatment (betaxolol HCl two times
a day and dorzolamide HCl three times a day) were 26
mmHg (OD) and 24 mmHg (OS). Severe loss (OU) of
visual field was observed, and cup/disk ratios were 0.8
(OD) and 0.6 (OS). Because her sister and one of her
daughters were also given diagnoses of POAG, a genetic
basis for its etiology could be suggested.
Mutations of the TIGR/MYOC gene were detected by
SSCP analysis and were confirmed by sequence analysis.
SSCP followed by sequence analysis of the proband, in-
dividual 3, revealed a CrT transition at nucleotide 201
in exon 1. This alteration resulted in a nonsense mu-
tation at codon 46 (argininerTAG, amber; fig. 1Ca).
The complete TIGR/MYOC coding region of the pro-
band, individual 3, was sequenced to confirm that there
was no alteration other than a C201T transition. This
mutation was presumed to result in a truncated protein
with 45 amino acids. This proband carried only mutated
alleles (fig. 1B), which was indicative of homozygosity
for the TIGR/MYOC gene. Further analysis of her fam-
ily revealed that her father, mother, and sister were het-
erozygous forTIGR/MYOC, apparently without any de-
tectable symptom. The proband’s brother, individual 5,
had two normal copies and did not have any symptoms
of POAG. The homozygote with this mutation is severely
affected, whereas heterozygotes do not display any de-
tectable POAG symptom. Thus, this family shows pos-
sible autosomal recessive inheritance of JOAG, whereas
other families, which have been described elsewhere,
show autosomal dominant inheritance. The heterozy-
gotes may develop POAG later in life, because it is
known that late-onset POAG shows age-dependent pen-
etrance. Another possibility is that, because of consan-
guinity, the proband is homozygous at other loci that
may modify the glaucoma phenotype. Importantly, there
was an individual with the C201T mutation in the con-
trol group (1/106), whose POAG status has not been
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Table 2
Clinical Data on Members of a Family with Familial JOAG and Their Genotypes for the MYOC Gene, Determined by SSCP and
Sequencing
PEDIGREEa
AGE
(years)
VERTICAL CUP/
DISK RATIO
TENSION
(mmHg)
GONIOSCOPY VISUAL FIELDb TREATMENT GENOTYPEcOD OS OD OS
1 42 .5 .5 22 24 IV(D40r) NA (OU) None Heterozygous
2 40 .4 .3 20 20 IV(D40r) NA (OU) None Heterozygous
3 15 .4 .5 29 30 IV(D45r) Nasal step (OU) Trabe (OU) Homozygous
4 13 .4 .5 22 22 IV(D40r) NA (OU) None Heterozygous
5 12 .6 .4 17 17 IV(D40r) NA (OU) None Wild type
a As in figure 1A.
b NA  not affected.
c As determined by SSCP and sequencing.
documented. This suggests that the C201T mutation
may not be so rare in the Korean population, which
supports the notion of autosomal recessive inheritance
of JOAG. However, at this point, we cannot exclude the
possibility that the proband’s parents are genetically re-
lated. Whereas further study is required to determine the
recessive inheritance for JOAG/POAG, this family pro-
vides an opportunity to elucidate a molecular mecha-
nism for TIGR/MYOC in POAG pathogenesis.
The mutation identified in a different family was het-
erozygous and was confirmed to be a CrT transition at
nucleotide 1123 (fig. 1Cb). None of the 106 patients
in the control group was found to contain the same
mutation. The change resulted in the conversion
Thr353 Ile (fig. 1B, lane 6, and Cb). This mutation re-
sided in the olfactomedin-homology region in the third
exon yet was different from all the mutations in the
TIGR/MYOC gene that have been reported to date.
Threonine at 353 residue is a putative phosphorylation
site by protein kinase C, predicted by the PROSITE Pat-
tern DB search program. Thus, the phosphorylation of
TIGR/MYOC may play a role in the regulation of IOP
in trabecular-meshwork cells.
The prevalence of C201T and C1123T mutations in
the TIGR/MYOC gene in Korean patients was estimated
by screening 45 unrelated patients with JOAG/POAG.
The prevalence of each mutation in the TIGR/MYOC
gene was 1 (2.2%) of 45 in patients with JOAG/POAG;
thus the combined prevalence was 4.4%.
With support from another report (Kee and Ahn
1997), the present study indicates that the mutations in
the TIGR/MYOC gene are responsible for JOAG/POAG
in Korean patients. That report also described a phe-
notypic homozygote with JOAG linked to GLC1A, and
it alluded to the autosomal recessive inheritance of
JOAG. The analysis of the function of the different mu-
tant forms of TIGR/MYOC in the regulation of IOP will
enhance our understanding of POAG pathogenesis.
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